These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36585414)

  • 1. Profiling placental DNA methylation associated with maternal SSRI treatment during pregnancy.
    Inkster AM; Konwar C; Peñaherrera MS; Brain U; Khan A; Price EM; Schuetz JM; Portales-Casamar É; Burt A; Marsit CJ; Vaillancourt C; Oberlander TF; Robinson WP
    Sci Rep; 2022 Dec; 12(1):22576. PubMed ID: 36585414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy.
    Non AL; Binder AM; Kubzansky LD; Michels KB
    Epigenetics; 2014 Jul; 9(7):964-72. PubMed ID: 24751725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation in cord blood in association with prenatal depressive symptoms.
    Kallak TK; Bränn E; Fransson E; Johansson Å; Lager S; Comasco E; Lyle R; Skalkidou A
    Clin Epigenetics; 2021 Apr; 13(1):78. PubMed ID: 33845866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.
    Gurnot C; Martin-Subero I; Mah SM; Weikum W; Goodman SJ; Brain U; Werker JF; Kobor MS; Esteller M; Oberlander TF; Hensch TK
    Epigenetics; 2015; 10(5):361-72. PubMed ID: 25891251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-cohort analysis of autosomal DNA methylation sex differences in the term placenta.
    Inkster AM; Yuan V; Konwar C; Matthews AM; Brown CJ; Robinson WP
    Biol Sex Differ; 2021 May; 12(1):38. PubMed ID: 34044884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study.
    Edvinsson Å; Hellgren C; Kunovac Kallak T; Åkerud H; Skalkidou A; Stener-Victorin E; Fornes R; Spigset O; Lager S; Olivier J; Sundström-Poromaa I
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):479. PubMed ID: 31805950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
    Pawluski JL; Brain UM; Underhill CM; Hammond GL; Oberlander TF
    Psychoneuroendocrinology; 2012 Jul; 37(7):1019-28. PubMed ID: 22177580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sculpting infant soothability: the role of prenatal SSRI antidepressant exposure and neonatal SLC6A4 methylation status.
    Gartstein MA; Hookenson KV; Brain U; Devlin AM; Grunau RE; Oberlander TF
    Dev Psychobiol; 2016 Sep; 58(6):745-58. PubMed ID: 27254389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
    Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
    Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.
    Oberlander TF; Papsdorf M; Brain UM; Misri S; Ross C; Grunau RE
    Arch Pediatr Adolesc Med; 2010 May; 164(5):444-51. PubMed ID: 20439795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure.
    Oberlander TF; Grunau R; Mayes L; Riggs W; Rurak D; Papsdorf M; Misri S; Weinberg J
    Early Hum Dev; 2008 Oct; 84(10):689-97. PubMed ID: 18639992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.
    Knickmeyer RC; Meltzer-Brody S; Woolson S; Hamer RM; Smith JK; Lury K; Gilmore JH
    Neuropsychopharmacology; 2014 Oct; 39(11):2611-21. PubMed ID: 24837031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study.
    van der Veere CN; de Vries NKS; van Braeckel KNJA; Bos AF
    Early Hum Dev; 2020 Aug; 147():105075. PubMed ID: 32504880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
    Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
    Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment.
    Edvinsson Å; Hoyer A; Hansson M; Kallak TK; Sundström-Poromaa I; Skalkidou A; Lager S
    Ups J Med Sci; 2020 Feb; 125(1):30-36. PubMed ID: 31960733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.